Technology, Research and Service
Life, Health, and Technology
Sinphar's pharmaceutical plant has achieved multiple quality certifications, including PIC/S GMP, ISO 9001, ISO 17025, ISO 14001, ISO 22000, and ISO45001 in addition to GMP inspection by Japanese PMDA.
With years of drug manufacturing experiences, Sinphar holds strong capabilities in R&D, technological development, and quality management, including product design development, consigned manufacturing, regulatory inspections and registration, IP management, and market strategies. Such capability renders Sinphar a highly reliable partner for expansion in the domestic and foreign markets.
Oncology Drug Center
The plant produces anti-cancer pharmaceuticals such as injections, solid reagents, and hormone reagents, all of which have passed PIC/S GMP certification. Plant 1 is the only factory in Taiwan that has passed TFDA certification and adopts closed system to manufacture cytotoxic agent (coated tablet).
This plant was constructed in 2012 and has a total base area of 3,423 m2 and building area of 1,443 m2. The plant has passed PIC/S GMP and Japanese PMDA inspections. Plant 2 is the only factory in Taiwan that adopts an isolated, automated isolator in its entire production line to manufacture cytotoxic injections. Purchasing cutting-edge production technologies from European countries, the plant holds adequate production capacity to supply the demand of the Asian market.
This plant has received quality certifications, including ISO 9001, ISO 17025, ISO 14001, ISO 22000, OHSAS, HACCP, GHP and HALAL and is equipped with fully functional high-performance production facilities.
Using top-notch R&D technologies, the plant produces a wide variety of medical products, such as tablets, soft gel capsules, and powdered, canned special nutrient products.With a full range of specialized services from prescription design, process design, specification formulation, and ingredient testing, the plant can fulfill the rapidly changing market demands.
The plant primarily manufactures body cleaning products such as shampoo, body wash, tonic water, lotions, moisturizer, sunscreen lotion, and serums.
Combining pharmaceutical production experiences with cosmetic production technologies, the plant provides increased quality assurance, stringently controls process conditions, and reduces the chances of bacterial contamination in production sites to achieve safety and quality assurance.
Pharmaceutical Packaging Plant
Sinphar Group invested in the establishment of ZuniMed Biotech in 2012, which focuses on producing pharmaceutical grade plastic containers and medical instruments. ZuniMed Biotech has passed GMP inspections and acquired ISO15378 certification for international pharmaceutical packaging. It is a specialized manufacturing plant that produces pharmaceutical grade plastic container for use in Class 100000 clean room.
Its principal products include eye drop bottles, dry canister, tablet bottle, and various medical grade plastic containers. With integrated radiation sterilization processing, the plant is able to meet hygiene requirements for pharmaceutical grade containers and also fulfill pharmaceutical validation standards.The establishment of ZuniMed Biotech completes the upstream, midstream, downstream integration of drug development, production, packaging, supply and marketing, making Sinphar Group a single entity that supplies a comprehensive range of pharmaceutical products.